The FDA approval of daratumumab and hyaluronidase-fihj for high-risk smoldering MM shifts care beyond watchful waiting, notes Peter Voorhees, MD. AQUILA enrolled 390 high-risk patients randomized 1:1 ...
COMMENT: Verstappen’s growing angst with F1 from all angles is obvious and, writes Kieran Jackson, a year-out could reinvigorate the Dutchman ...
It's been two months since Nancy Guthrie's alleged abduction. Why the anguishing wait for her return has continued.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results